Literature DB >> 33479370

Deep learning predicts postsurgical recurrence of hepatocellular carcinoma from digital histopathologic images.

Daniel L Rubin1,2, Jeanne Shen3,4, Rikiya Yamashita1,2, Jin Long2, Atif Saleem5.   

Abstract

Recurrence risk stratification of patients undergoing primary surgical resection for hepatocellular carcinoma (HCC) is an area of active investigation, and several staging systems have been proposed to optimize treatment strategies. However, as many as 70% of patients still experience tumor recurrence at 5 years post-surgery. We developed and validated a deep learning-based system (HCC-SurvNet) that provides risk scores for disease recurrence after primary resection, directly from hematoxylin and eosin-stained digital whole-slide images of formalin-fixed, paraffin embedded liver resections. Our model achieved concordance indices of 0.724 and 0.683 on the internal and external test cohorts, respectively, exceeding the performance of the standard Tumor-Node-Metastasis classification system. The model's risk score stratified patients into low- and high-risk subgroups with statistically significant differences in their survival distributions, and was an independent risk factor for post-surgical recurrence in both test cohorts. Our results suggest that deep learning-based models can provide recurrence risk scores which may augment current patient stratification methods and help refine the clinical management of patients undergoing primary surgical resection for HCC.

Entities:  

Year:  2021        PMID: 33479370      PMCID: PMC7820423          DOI: 10.1038/s41598-021-81506-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  27 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; María Reig; Jordi Bruix
Journal:  Lancet       Date:  2018-01-05       Impact factor: 79.321

Review 2.  Hepatocellular Carcinoma.

Authors:  Augusto Villanueva
Journal:  N Engl J Med       Date:  2019-04-11       Impact factor: 91.245

Review 3.  A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability.

Authors:  Manuel Rodríguez-Perálvarez; Tu Vinh Luong; Lorenzo Andreana; Tim Meyer; Amar Paul Dhillon; Andrew Kenneth Burroughs
Journal:  Ann Surg Oncol       Date:  2012-11-13       Impact factor: 5.344

4.  Classification and Prognosis Prediction from Histopathological Images of Hepatocellular Carcinoma by a Fully Automated Pipeline Based on Machine Learning.

Authors:  Haotian Liao; Tianyuan Xiong; Jiajie Peng; Lin Xu; Mingheng Liao; Zhen Zhang; Zhenru Wu; Kefei Yuan; Yong Zeng
Journal:  Ann Surg Oncol       Date:  2020-01-08       Impact factor: 5.344

5.  Chronic hepatitis. An update on terminology and reporting.

Authors:  K P Batts; J Ludwig
Journal:  Am J Surg Pathol       Date:  1995-12       Impact factor: 6.394

6.  Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.

Authors:  Clifford A Hudis; William E Barlow; Joseph P Costantino; Robert J Gray; Kathleen I Pritchard; Judith-Anne W Chapman; Joseph A Sparano; Sally Hunsberger; Rebecca A Enos; Richard D Gelber; Jo Anne Zujewski
Journal:  J Clin Oncol       Date:  2007-05-20       Impact factor: 44.544

7.  Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.

Authors:  Toshiya Kamiyama; Kazuaki Nakanishi; Hideki Yokoo; Hirofumi Kamachi; Munenori Tahara; Tatsuhiko Kakisaka; Yosuke Tsuruga; Satoru Todo; Akinobu Taketomi
Journal:  World J Surg Oncol       Date:  2012-06-14       Impact factor: 2.754

Review 8.  A global view of hepatocellular carcinoma: trends, risk, prevention and management.

Authors:  Ju Dong Yang; Pierre Hainaut; Gregory J Gores; Amina Amadou; Amelie Plymoth; Lewis R Roberts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08-22       Impact factor: 73.082

9.  OpenSlide: A vendor-neutral software foundation for digital pathology.

Authors:  Adam Goode; Benjamin Gilbert; Jan Harkes; Drazen Jukic; Mahadev Satyanarayanan
Journal:  J Pathol Inform       Date:  2013-09-27

10.  An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.

Authors:  Jianfang Liu; Tara Lichtenberg; Katherine A Hoadley; Laila M Poisson; Alexander J Lazar; Andrew D Cherniack; Albert J Kovatich; Christopher C Benz; Douglas A Levine; Adrian V Lee; Larsson Omberg; Denise M Wolf; Craig D Shriver; Vesteinn Thorsson; Hai Hu
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

View more
  6 in total

Review 1.  Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma.

Authors:  Julien Calderaro; Tobias Paul Seraphin; Tom Luedde; Tracey G Simon
Journal:  J Hepatol       Date:  2022-06       Impact factor: 30.083

Review 2.  Role of three-dimensional printing and artificial intelligence in the management of hepatocellular carcinoma: Challenges and opportunities.

Authors:  Chrysanthos D Christou; Georgios Tsoulfas
Journal:  World J Gastrointest Oncol       Date:  2022-04-15

Review 3.  Deep learning in hepatocellular carcinoma: Current status and future perspectives.

Authors:  Joseph C Ahn; Touseef Ahmad Qureshi; Amit G Singal; Debiao Li; Ju-Dong Yang
Journal:  World J Hepatol       Date:  2021-12-27

Review 4.  Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction.

Authors:  David Nam; Julius Chapiro; Valerie Paradis; Tobias Paul Seraphin; Jakob Nikolas Kather
Journal:  JHEP Rep       Date:  2022-02-02

Review 5.  The evolving role of morphology in endometrial cancer diagnostics: From histopathology and molecular testing towards integrative data analysis by deep learning.

Authors:  Sarah Fremond; Viktor Hendrik Koelzer; Nanda Horeweg; Tjalling Bosse
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

Review 6.  The Role of Artificial Intelligence in Early Cancer Diagnosis.

Authors:  Benjamin Hunter; Sumeet Hindocha; Richard W Lee
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.